US FDA accepts application for psoriasis drug: Sun Pharma

The FDA filing acceptance follows the acceptance of the regulatory filing of tildrakizumab by the European Medicines Agency (EMA) in March 2017.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news